Effects of haloperidol and risperidone on the expression of heat shock protein 70 in MK-801-treated rat C6 glioma cells

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 1793-1797

  Roh, Kyungsoo ^a   Roh, Sungwon ^a   Yang, Byung Hwan ^a   Lee, Jun Seok ^b   Chai, Young Gyu ^c   Choi, Mi Ran ^a   Park, Yong Chon ^a   Kim, Dai Jin ^d   Kim, Daeho ^a   Choi, Joonho ^a   Kim, Seok Hyeon ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Catholic Kwandong University   (South Korea)

^c Hanyang University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Haloperidol; HSP; MK 801; Rat; Risperidone; Schizophrenia

Indexed keywords

DIZOCILPINE; HALOPERIDOL; HEAT SHOCK PROTEIN 70; MONOCLONAL ANTIBODY; RISPERIDONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; GLIOMA CELL; IMMUNOBLOTTING; NONHUMAN; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

ANIMALS; CELL LINE, TUMOR; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; GLIOMA; HALOPERIDOL; HSP70 HEAT-SHOCK PROTEINS; LINEAR MODELS; RATS; RISPERIDONE; TIME FACTORS;

EID: 56449125613     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.07.018     Document Type: Article

References (51)

1. al-Amin H.A., and Schwarzkopf S.B. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia. Biol Psychiatry 40 (1996) 744-754
2. Albasanz J.L., Ros M., and Martín M. Characterization of metabotropic glutamate receptors in rat C6 glioma cells. Eur J Pharmacol 326 (1997) 85-91
3. Amano T., Yamakuni T., Okabe N., Kuwahara R., Ozawa F., and Hishinuma F. Regulation of nerve growth factor and nerve growth factor receptor production by NMDA in C6 glioma cells. Brain Res Mol Brain Res 14 (1992) 35-42
4. Barres B.A., Chun L.L., and Corey D.P. Ion channels in vertebrate glia. Annu Rev Neurosci 13 (1990) 441-474
5. Bates P.R., Hawkins A., Mahadik S.P., and McGrath J.J. Heat stress lipids and schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55 (1996) 101-107
6. Buchanan R.W., and Carpenter W.T. Concept of schizophrenia. In: Sadock, B.J., Sadock, and V.A. (Eds). Kaplan & Sadock's comprehensive textbook of psychiatry. 8th ed (2005), Lippincott Williams & Wilkins, Philadelphia 1329-1345
7. Buckland P.R., Marshall R., Watkins P., and McGuffin P. Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic l-amino acid decarboxylase mRNA levels. Brain Res Mol Brain Res 49 (1997) 266-270
8. Chu B., Soncin F., Price B.D., Stevenson M.A., and Calderwood S.K. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J Biol Chem 271 (1996) 30847-30857
9. Cussac D., Duqueyroix D., Newman-Tancredi A., and Millan M.J. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors. Psychopharmacology (Berl) 162 (2002) 168-177
10. Dickerson J., and Sharp F.R. Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801. Neuropsychopharmacology 31 (2006) 1420-1430
11. Egerton A., Reid L., McKerchar C.E., Morris B.J., and Pratt J.A. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology (Berl) 179 (2005) 77-84
12. Elliott J.M., Newberry N.R., Cholewinski A.J., Bartrup J.T., Briddon S.J., Carey J.E., et al. Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat C6 glioma cells. Neuroscience 69 (1995) 1119-1131
13. Ganguli R., Brar J.S., Solomon W., Chengappa K.N., and Rabin B.S. Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiatry Res 44 (1992) 113-123
14. Hartl F.U. Molecular chaperones in cellular protein folding. Nature 381 (1996) 571-580
15. Hashimoto K., Tomitaka S., Narita N., Minabe Y., Iyo M., and Fukui S. Induction of heat shock protein (HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of sigma receptor ligands. Addict Biol 1 (1996) 61-70
16. Hashimoto K., Minabe Y., and Iyo M. Expression of cyclooxygenase-2 mRNA in rat retrosplenial cortex following administration of phencyclidine. Brain Res 762 (1997) 259-263
17. Hendrick J.P., and Hartl F.U. Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem 62 (1993) 349-384
18. Ho B.C., Black D.W., and Andreasen N.C. Schizophrenia and other psychotic disorders. In: Hales, R.E., Yudofsky, and S.C. (Eds). Textbook of clinical psychiatry. 4th ed (2003), American Psychiatric Publishing Inc., Washington, DC 379-438
19. Hosli L., Hosli E., Baggi M., Bassetti C., and Uhr M. Action of dopamine and serotonin on the membrane potential of cultured astrocytes. Exp Brain Res 65 (1987) 482-485
20. 2 receptors - implications for models of schizophrenia. Mol Psychiatry 7 (2002) 837-844
21. Kato S., Negishi K., Mawatari K., and Kuo C.H. A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience 48 (1992) 903-914
22. Kim J.J., Lee S.J., Toh K.Y., Lee C.U., Lee C., and Paik I.H. Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia. Schizophr Res 52 (2001) 127-135
23. Kim S.K., Kwon G.Y., Shin S.W., and Choe B.K. Expression of neuropeptide Y by glutamatergic stimulation in rat C6 glioma cells. Neurochem Int 36 (2000) 19-26
24. Kirch D.G. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr Bull 19 (1993) 355-370
25. Krebs C., Fernandes H.B., Sheldon C., Raymond L.A., and Baimbridge K.G. Functional NMDA receptors subtype 2B expressed in astrocytes after ischemia in vivo and anoxia in vitro. J Neurosci 23 (2003) 3364-3372
26. Lewis S.W., and Murray R.M. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res 21 (1987) 413-421
27. Li D.P., Periyasamy S., Jones T.J., and Sanchez E.R. Heat and chemical shock potentiation of glucocorticoid receptor transactivation requires heat shock factor (HSF) activity. Modulation of HSF by vanadate and wortmannin. J Biol Chem 275 (2000) 26058-26065
28. Luo Y., Kokkonen G.C., Wang X., Neve K., and Roth G.R. D2 dopamine receptors stimulate mitogenesis through PTX-sensitive G proteins and Ras involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells. J Neurochem 71 (1998) 980-990
29. McGrath J.J. Myths and plain truths about schizophrenia epidemiology - the NAPE lecture 2004. Acta Psychiatr Scand 111 (2005) 4-11
30. Mednick S.A., Machon R.A., Huttunen M.O., and Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45 (1988) 189-192
31. Mivechi N.F., and Giaccia A.J. Mitogen-activated protein kinase acts as a negative regulator of the heat shock response in NIH3T3 cells. Cancer Res 55 (1995) 5512-5519
32. Nakahara T., Kuroki T., Hondo H., Tsutsumi T., Fukuda K., Yao H., et al. Effects of atypical drugs vs. haloperidol on expression of heat shock protein in the discrete brain regions of phencyclidine-treated rats. Brain Res Mol Brain Res 73 (1999) 193-197
33. Olney J.W., and Farber N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13 (1995) 335-345
34. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., and Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science 254 (1991) 1515-1518
35. Olszewski R.T., Bukhari N., Zhou J., Kozikowski A.P., Wroblewski J.T., Shamimi-Noori S., et al. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J Neurochem 89 (2004) 876-885
36. O'Neill M.F., Hicks C.A., Shaw G., Parameswaran T., Cardwell G.P., and O'Neill M.J. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine. J Pharmacol Exp Ther 287 (1998) 839-846
37. Pandey R.S., Gupta A.K., and Chaturvedi U.C. Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry 16 (1981) 1123-1136
38. Pratt W.B. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 268 (1993) 21455-21458
39. Satoh J., and Kim S.U. HSP72 induction by heat stress in human neurons and glial cells in culture. Brain Res 653 (1994) 243-250
40. Schipke C.G., Ohlemeyer C., Matyash M., Nolte C., Kettenmann H., and Kirchhoff F. Astrocytes of mouse neocortex express functional N-methyl-d-aspartate receptors. FASEB J. 15 (2001) 1270-1272
41. Schlesinger M.J. Heat shock proteins. J Biol Chem 265 (1990) 12111-12114
42. Schwarz M.J., Riedel M., Gruber R., Ackenheil M., and Müller N. Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease. Am J Psychiatry 156 (1999) 1103-1104
43. Sharp F.R., Butman M., Wang S., Koistinaho J., Graham S.H., Sagar S.M., et al. Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J Neurosci Res 33 (1992) 605-616
44. Sharp F.R., Butman M., Aardalen K., Nickolenko J., Nakki R., Massa S.M., et al. Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. Psychopharmacol Bull 30 (1994) 555-560
45. Sharp F.R., Massa S.M., and Swanson R.A. Heat-shock protein protection. Trends Neurosci 22 (1999) 97-99
46. Shinno H., Mikuni M., Saitoh K., Tomita U., Yamawaki S., and Takahashi K. Metabotropic glutamate receptor in C6BU-1 glioma cell has NMDA receptor-ion channel complex-like properties and interacts with serotonin2 receptor-stimulated signal transduction. J Neurochem 63 (1994) 1346-1353
47. Singh J., and Kaur G. HSP70 induction and oxidative stress protection mediated by a subtoxic dose of NMDA in the retinoic acid-differentiated C6 glioma cell line. Brain Res Bull 69 (2006) 37-47
48. Sirota P., Schild K., Elizur A., Djaldetti M., and Fishman P. Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients. Prog Neuro-psychopharmacol Biol Psychiatry 19 (1995) 75-83
49. Tamminga C.A., Buchanan R.W., and Gold J.M. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 13 (1998) S21-26
50. Thomas E.A., Matli J.R., Hu J.L., Carson M.J., and Sutcliffe J.G. Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells. J Neurosci Res 61 (2000) 75-81
51. Wright P., Gill M., and Murray R.M. Schizophrenia: genetics and the maternal immune response to viral infection. Am J Med Genet 48 (1993) 40-46